# A Study to Investigate Multiple Ascending Doses and Relative Bioavailability of AZD5004 in Healthy Participants

> **NCT06555822** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 31 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** AZD5004
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06555822
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-08-15
- **Primary completion:** 2025-03-06
- **Final completion:** 2025-03-06
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2025-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06555822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06555822, "A Study to Investigate Multiple Ascending Doses and Relative Bioavailability of AZD5004 in Healthy Participants". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06555822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*